1.Prognostic Impact of Peripelvic Fat Invasion in pT3 Renal Pelvic Transitional Cell Carcinoma.
Kang Su CHO ; Nam Hoon CHO ; Sung Yul PARK ; Sung Yong CHO ; Young Deuk CHOI ; Byung Ha CHUNG ; Seung Choul YANG ; Sung Joon HONG
Journal of Korean Medical Science 2008;23(3):434-438
Renal pelvic transitional cell carcinoma (TCC), which invades beyond muscularis into peripelvic fat or the renal parenchyma, is diagnosed as stage pT3 despite its structural complexity. We evaluated the prognostic impact of peripelvic fat invasion in pT3 renal pelvic TCC. Between 1986 and 2004, the medical records on 128 patients who were surgically treated for renal pelvic TCC were retrospectively reviewed. Sixty patients with pT3 disease were eligible for the main analysis. The prognostic impact of various clinicopathological factors was analyzed using univariate and multivariate analyses. On univariate analysis, sex, age, concomitant bladder tumors, concomitant ureter tumors, lymphadenectomy, adjuvant chemotherapy, tumor grade, multiplicity, renal parenchymal invasion, and carcinoma in situ did not influence the disease-specific survival (p>0.05). By contrast, peripelvic fat invasion, lymph node invasion, and lymphovascular invasion were each significantly associated with disease-specific survival (p<0.05). Multivariate analysis showed that peripelvic fat invasion (p=0.012) and lymph node invasion (p=0.004) were independent prognostic factors. In conclusion, peripelvic fat invasion is a strong prognostic factor in pT3 renal pelvic TCC. Thus, systemic adjuvant therapy should be considered in the presence of peripelvic fat invasion, even if the lymph nodes are not involved.
Adipose Tissue/*pathology
;
Adult
;
Aged
;
Aged, 80 and over
;
Carcinoma, Transitional Cell/mortality/*pathology/surgery
;
Female
;
Follow-Up Studies
;
Humans
;
Kidney Neoplasms/mortality/*pathology/surgery
;
Lymph Nodes/pathology
;
Male
;
Middle Aged
;
Neoplasm Invasiveness
;
Pelvis
;
Prognosis
;
Retrospective Studies
;
Survival Analysis
2.High-Grade Hydronephrosis Predicts Poor Outcomes After Radical Cystectomy in Patients with Bladder Cancer.
Dong Suk KIM ; Kang Su CHO ; Young Hoon LEE ; Nam Hoon CHO ; Young Taek OH ; Sung Joon HONG
Journal of Korean Medical Science 2010;25(3):369-373
We examined whether the presence and severity of preoperative hydronephrosis have prognostic significance in patients who underwent radical cystectomy for transitional cell carcinoma of the bladder. The medical records of 457 patients who underwent radical cystectomy for bladder cancer between 1986 and 2005 were retrospectively reviewed. Following the Society for Fetal Urology grading system, patients were divided into low-, and high-grade hydronephrosis groups. Clinicopathologic factors associated with preoperative hydronephrosis and survival were evaluated. Of a total of 406 patients, unilateral hydronephrosis was found in 74 (18.2%), bilateral hydronephrosis in 11 (2.7%), and no hydronephoris in 321 (79.1%). Low-grade hydronephrosis was found in 57 (12.2%) patients and high-grade hydronephrosis in 28 (6%). Preoperative hydronephrosis was related to higher pT stage and lymph node invasion. In univariate analysis, the presence of hydronephrosis, hydronephrosis grade, age, pT and pN stage, tumor grade, surgical margin, number of retrieved nodes, carcinoma in situ, and lymphovascular invasion were significant prognostic factors for cancer-specific survival. In multivariate analysis, bilateral hydronephrosis and high-grade hydronephrosis remained significant predictors for decreased survival. The presence of preoperative hydronephrosis, and high-grade hydronephrosis are significant prognostic factors in patients with bladder cancer after radical cystectomy.
Adult
;
Aged
;
Carcinoma, Transitional Cell/diagnosis/*mortality/pathology/*surgery
;
*Cystectomy
;
Female
;
Humans
;
Hydronephrosis/classification/*pathology
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Prognosis
;
Retrospective Studies
;
Survival Rate
;
Treatment Outcome
;
Urinary Bladder Neoplasms/diagnosis/*mortality/pathology/*surgery
3.Preoperative Underweight Patients with Upper Tract Urothelial Carcinoma Survive Less after Radical Nephroureterectomy.
Ho Won KANG ; Hae Do JUNG ; Yun Sok HA ; Tae Hwan KIM ; Tae Gyun KWON ; Seok Soo BYUN ; Seok Joong YUN ; Wun Jae KIM ; Young Deuk CHOI
Journal of Korean Medical Science 2015;30(10):1483-1489
The prognostic impact of body mass index (BMI) in patients with upper tract urothelial carcinoma (UTUC) is an ongoing debate. Our study aimed to investigate the prognostic role of BMI in patients treated with radical nephroureterectomy (RNU) for UTUC from a multi-institutional Korean collaboration. We retrospectively reviewed data from 440 patients who underwent RNU for UTUC at four institutions in Korea. To avoid biasing the survival estimates, patients who had previous or concomitant muscle-invasive bladder tumors were excluded. BMI was categorized into approximate quartiles with the lowest quartile assigned to the reference group. Kaplan-Meier and multivariate Cox regression analyses were performed to assess the influence of BMI on survival. The lower quartile BMI group showed significantly increased overall mortality (OM) and cancer specific mortality (CSM) compared to the 25%-50% quartiles and upper quartile BMI groups. Kaplan-Meier estimates showed similar results. Based on multivariate Cox regression analysis, preoperative BMI as a continuous variable was an independent predictor for OM and CSM. In conclusion, preoperative underweight patients with UTUC in Korea survive less after RNU. Preoperative BMI may provide additional prognostic information to establish risk factors.
Aged
;
Asian Continental Ancestry Group
;
Body Mass Index
;
Carcinoma, Transitional Cell/*mortality
;
Cystectomy/*mortality
;
Female
;
Humans
;
Kidney Pelvis/surgery
;
Male
;
Nephrectomy/*mortality
;
Republic of Korea
;
Retrospective Studies
;
Thinness/*mortality
;
Ureter/surgery
;
Urinary Bladder/surgery
;
Urologic Neoplasms/*mortality/pathology/*surgery
;
Urothelium/pathology/*surgery
4.The prognostic impact of perioperative blood transfusion on survival in patients with bladder urothelial carcinoma treated with radical cystectomy.
Joong Sub LEE ; Hyung Suk KIM ; Chang Wook JEONG ; Cheol KWAK ; Hyeon Hoe KIM ; Ja Hyeon KU
Korean Journal of Urology 2015;56(4):295-304
PURPOSE: The aim of our study was to assess the influence of perioperative blood transfusion (PBT) on survival outcomes following radical cystectomy (RC) and pelvic lymph node dissection (PLND). MATERIALS AND METHODS: We reviewed and analyzed the clinical data of 432 patients who underwent RC for bladder cancer from 1991 to 2012. PBT was defined as the transfusion of allogeneic red blood cells during RC or postoperative hospitalization. RESULTS: Of all patients, 315 patients (72.9%) received PBT. On multivariate logistic regression analysis, female gender (p=0.015), a lower preoperative hemoglobin level (p=0.003), estimated blood loss>800 mL (p<0.001), and performance of neoadjuvant chemotherapy (p<0.001) were independent risk factors related to requiring perioperative transfusions. The receipt of PBT was associated with increased overall mortality (hazard ratio, 1.91; 95% confidence interval, 1.25-2.94; p=0.003) on univariate analysis, but its association was not confirmed by multivariate analysis (p=0.058). In transfused patients, a transfusion of >4 packed red blood cell units was an independent predictor of overall survival (p=0.007), but not in cancer specific survival. CONCLUSIONS: Our study was not conclusive to detect a clear association between PBT and survival after RC. However, the efforts should be made to continue limiting the overuse of transfusion especially in patients who are expected to have a high probability of PBT, such as females and those with a low preoperative hemoglobin level and history of neoadjuvant chemotherapy.
Aged
;
*Blood Transfusion/methods/mortality
;
*Carcinoma, Transitional Cell/mortality/pathology/surgery
;
Disease-Free Survival
;
Female
;
Humans
;
Kaplan-Meier Estimate
;
Lymph Node Excision/*methods
;
Male
;
Middle Aged
;
Pelvis/pathology/surgery
;
Perioperative Care/methods
;
Prognosis
;
Republic of Korea/epidemiology
;
Retrospective Studies
;
Risk Factors
;
Treatment Outcome
;
Urinary Bladder/pathology
;
*Urinary Bladder Neoplasms/mortality/pathology/surgery
5.Impact of adjuvant chemotherapy in patients with upper tract urothelial carcinoma and lymphovascular invasion after radical nephroureterectomy.
Kwang Suk LEE ; Kwang Hyun KIM ; Young Eun YOON ; Kyung Hwa CHOI ; Seung Choul YANG ; Woong Kyu HAN
Korean Journal of Urology 2015;56(1):41-47
PURPOSE: To evaluate the impact of adjuvant chemotherapy (AC) in patients with upper tract urothelial carcinoma and lymphovascular invasion (LVI) after radical nephroureterectomy (RNU). MATERIALS AND METHODS: We retrospectively analyzed the clinical records and clinicopatholgic outcomes of patients (n=552) treated with RNU between 1986 and 2013. Patients treated with neoadjuvant chemotherapy and those for whom LVI status was not recorded were excluded. Patients were divided into two groups according to LVI (n=86) or no LVI (n=256). RESULTS: The study included 344 patients (240 men and 104 women) with a median of 53.9 months of follow-up (range, 1-297 months) after RNU. Tumors were organ confined (T2/N0) in 211 (61.3%) and tumor grade high in 291 (84.6%). AC was administered in 64 patients (18.6%). A total of 280 patients (81.4%) were treated with surgery alone. Patients with LVI tended to be older (p=0.049), have a higher pT stage (pT3/T4, p<0.001), be pN+ (p<0.001), have a high tumor grade (p<0.001), and experience recurrence (p<0.001). In the multivariate analysis, LVI was an independent prognostic factor for cancer-specific survival and overall survival (p=0.002 and p<0.001, respectively). The multivariate analysis demonstrated that in the subgroup of patients with LVI, AC was a significant prognostic factor for cancer-specific survival and overall survival (hazard ratio, 0.51; p=0.027 and hazard ratio, 0.50; p=0.025, respectively). CONCLUSIONS: AC does not seem to reduce mortality in patients with advanced upper tract urothelial carcinoma after RNU. In the subgroup of patients with LVI, AC had a positive impact on cancer-specific survival and overall survival. LVI would be helpful for selecting patients who are appropriate for AC.
Aged
;
Carcinoma, Transitional Cell/drug therapy/*mortality/surgery
;
*Chemotherapy, Adjuvant
;
Female
;
Follow-Up Studies
;
Humans
;
Kidney Neoplasms/drug therapy/*mortality/surgery
;
Lymphatic Metastasis
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Neoplasm Grading
;
Neoplasm Recurrence, Local
;
Neoplasm Staging
;
Nephrectomy
;
Prognosis
;
Retrospective Studies
;
Survival Rate
;
Ureter/pathology
;
Ureteral Neoplasms/drug therapy/*mortality/surgery
;
Urinary Tract/pathology